Answer
Zilbrysq (zilucoplan sodium) is contraindicated in patients with hypersensitivity to the active substance or any excipient, patients not currently vaccinated against Neisseria meningitidis, and patients with unresolved Neisseria meningitidis infection.
Sources for this answer
- Zilbrysq 32.4 mg solution for injection in pre filled syringeUCB Pharma Limited · emc · SmPC §4.3 Contraindications · Version 4Document updated
Sources checked